针对癌症免疫治疗的CAR工程天生的免疫细胞的景观
Ourania Tsahouridis1, Max Xu1, Feifei Song1
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nature cancer
|July 18, 2025
概括
化学抗原受体 (CAR) T细胞对血液癌症有希望,但对固体瘤没有希望. 这篇评论探讨了使用工程天生的免疫细胞,如NK细胞,以改善癌症免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T 细胞已经显著推进了淋巴细胞恶性瘤治疗.
- 卡尔-T细胞在固体瘤中尚未显示出可比的疗效.
- 限制包括功能限制和与当前CAR T细胞疗法相关的高成本.
研究的目的:
- 审查CAR工程天生的免疫细胞在癌症免疫治疗中的潜力和局限性.
- 探索超越传统CAR T细胞的新策略,用于固体瘤治疗.
- 讨论在基于CAR的癌症治疗中天生的免疫细胞的开发和应用.
主要方法:
- 关于CAR工程天生的免疫细胞的当前文献的综述.
- 分析克服CAR T细胞局限性的策略.
- 讨论用于CAR工程的各种先天性免疫细胞类型 (NK,NKT,γδ T,巨细胞).
主要成果:
- 在固体瘤中,CAR工程天生的免疫细胞为CAR T细胞提供了一个有希望的替代方案.
- 自然杀手 (NK) 细胞,NK T (NKT) 细胞,γδ T 细胞和巨细胞正在为CAR工程进行探索.
- 这些方法旨在增强抗瘤活性,并解决传统CAR T细胞的局限性.
结论:
- 通过CAR工程的先天性免疫细胞代表了癌症免疫疗法的发展前沿.
- 需要进一步的研究来优化这些策略,以便在固体瘤中临床应用.
- 基于先天性免疫细胞的CAR疗法有可能改善挑战性癌症患者的治疗结果.
更多相关视频
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cytotoxic T Cells-mediated Immune Response
2.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.2K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Vaccines
516
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
516
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


